FibroGen, Inc. (FGEN) has a market capitalization of $36.69M and trades at $9.07. The 52-week range is 4.85-21.95.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 0.2, Earnings Per Share (EPS) of $45.37, annual revenue of $6.44M.
The stock has a beta of 0.77, operates in the Healthcare sector.
